OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IMMP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Immutep (IMMP) Earnings Date & Reports

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IMMP is expected to report earnings to rise 633.50% to -14 cents per share on February 19

Q4'25

Est.

$-0.15

Q4'24

Beat

by $0.12

Q4'23

Missed

by $0.05

Q2'23

Est.

$-0.15

Q4'22

Beat

by $0.01

The last earnings report on February 26 showed earnings per share of -1 cents, beating the estimate of -14 cents. With 369.32K shares outstanding, the current market capitalization sits at 275.80M.

View a ticker or compare two or three

Compare

IMMP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IMMP
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMMP showed earnings on February 26, 2025. You can read more about the earnings report here.

View AI-Driven Trading for IMMP

A.I. Advisor

published General Information

General Information

a developer of anti-cancer therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

264 George Street

Phone

+61 283157003

Employees

Web

https://www.immutep.com